BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36726200)

  • 21. CCR3 deficiency is associated with increased osteoclast activity and reduced cortical bone volume in adult male mice.
    Rosendahl S; Sulniute R; Eklund M; Koskinen Holm C; Johansson MJO; Kindstedt E; Lindquist S; Lundberg P
    J Biol Chem; 2021; 296():100177. PubMed ID: 33303631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.
    Khalid AB; Slayden AV; Kumpati J; Perry CD; Berryhill SB; Crawford JA; Fatima I; Morselli M; Pellegrini M; Miranda-Carboni GA; Krum SA
    Bone; 2018 Nov; 116():78-86. PubMed ID: 30031905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.
    Hikata T; Takaishi H; Takito J; Hakozaki A; Furukawa M; Uchikawa S; Kimura T; Okada Y; Matsumoto M; Yoshimura A; Nishimura R; Reddy SV; Asahara H; Toyama Y
    Blood; 2009 Mar; 113(10):2202-12. PubMed ID: 18952894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excessive osteoclast activation by osteoblast paracrine factor RANKL is a major cause of the abnormal long bone phenotype in Apert syndrome model mice.
    Shin HR; Kim BS; Kim HJ; Yoon H; Kim WJ; Choi JY; Ryoo HM
    J Cell Physiol; 2022 Apr; 237(4):2155-2168. PubMed ID: 35048384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling.
    Samee N; Geoffroy V; Marty C; Schiltz C; Vieux-Rochas M; Levi G; de Vernejoul MC
    Am J Pathol; 2008 Sep; 173(3):773-80. PubMed ID: 18669617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bif-1/Endophilin B1/SH3GLB1 regulates bone homeostasis.
    Touyama K; Khan M; Aoki K; Matsuda M; Hiura F; Takakura N; Matsubara T; Harada Y; Hirohashi Y; Tamura Y; Gao J; Mori K; Kokabu S; Yasuda H; Fujita Y; Watanabe K; Takahashi Y; Maki K; Jimi E
    J Cell Biochem; 2019 Nov; 120(11):18793-18804. PubMed ID: 31243813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory mechanisms of osteoblast and osteoclast differentiation.
    Katagiri T; Takahashi N
    Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
    Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling.
    Li S; Liu Q; Wu D; He T; Yuan J; Qiu H; Tickner J; Zheng SG; Li X; Xu J; Rong L
    Cell Death Dis; 2020 Sep; 11(9):762. PubMed ID: 32938907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss.
    Yu W; Zhong L; Yao L; Wei Y; Gui T; Li Z; Kim H; Holdreith N; Jiang X; Tong W; Dyment N; Liu XS; Yang S; Choi Y; Ahn J; Qin L
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33206630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation.
    Maruyama K; Kawagoe T; Kondo T; Akira S; Takeuchi O
    J Biol Chem; 2012 Aug; 287(34):29114-24. PubMed ID: 22773835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-196b-5p Regulates Osteoblast and Osteoclast Differentiation and Bone Homeostasis by Targeting SEMA3A.
    Xie Y; Zhou J; Tian L; Dong Y; Yuan H; Zhu E; Li X; Wang B
    J Bone Miner Res; 2023 Aug; 38(8):1175-1191. PubMed ID: 37221130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.
    Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A
    Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-κB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity.
    Furuya Y; Inagaki A; Khan M; Mori K; Penninger JM; Nakamura M; Udagawa N; Aoki K; Ohya K; Uchida K; Yasuda H
    J Biol Chem; 2013 Feb; 288(8):5562-71. PubMed ID: 23319583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
    Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y
    Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.